A site where you can find recommended contractors for non-clinical testing|effical " Non-Clinical CROs and Agencies " Hokudo Co.,Ltd.

Hokudo Co.,Ltd.

Table of Contents
Table of Contents

Hokudo Co.,Ltd. provides integrated non-clinical study, from study designing to data delivery. They provide high-quality data for evaluating drug efficacy, pharmacology, and safety study.

Features of Hokudo Co.,Ltd.’s Non-Clinical Study Services

Extensive efficacy evaluation across diverse disease models and animal species

Hokudo Co.,Ltd. offers a wide range of disease models; spinal cord injury, COPD, atopic dermatitis, hair growth, pain, inflammation, diabetes, and anti-aging. They offer various animal species, rodents(rats, mice), larger animals(pigs, sheep, rabbits)—allowing study designs tailored to diverse research needs.
They offer flexible study design for complex pharmacological studies with well-integrated platform.

Comprehensive safety testing, including simulated medical device use and mutagenicity evaluation

Hokudo Co.,Ltd. provides mutagenicity assessments such as bacterial reverse mutation test and chromosomal aberration test, as well as general toxicity testing (acute, subacute, dermal corrosion, sensitization, and eye irritation).
They perform simulated use testing for medical devices such as artificial bones and joints. This offers integrated safety evaluations for both pharmaceuticals and medical devices.

Flexible testing formats, from partial outsourcing to rental laboratory services

Hokudo Co.,Ltd. accommodates flexible arrangements to meet client needs—full study outsourcing, partial contracts, where clients handle administration or surgery while Hokudo Co.,Ltd. manages husbandry, observation, or support tasks.

Their facilities are also available for rental laboratories for those who might need a specialized set-up or for surgical training purposes. They support a wide spectrum of research and development targets.

Example of Disease Model at Hokudo Co.,Ltd.

COPD (Chronic Obstructive Pulmonary Disease) Model

Hokudo Co.,Ltd. provides pharmacological study in COPD model.
This model is induced by smoking exposure or bronchitis-like inflammation. It can reproduce COPD features such as airway inflammation, alveolar destruction, and reduced lung function.

It enables multi-parameter evaluation of drug efficacy by disease progression and is applicable to in vivo screening and efficacy evaluation.
With its strong clinical correlation to human respiratory conditions, this model serves as a valuable platform for research in respiratory diseases.

Reference:
https://www.hokudo.co.jp/4-1_kobetsushiken.html

Non-clinical study examples of EPHokudo’s Non-Clinical Study Example

Evaluation of motor function using a rat spinal cord injury model

Hokudo Co.,Ltd. conducts spinal cord injury model in rats using MASCIS Impactor to create controlled injuries.

Motor function is quantitatively assessed using the BBB (Basso, Beattie, Bresnahan) score, allowing researchers to monitor neural recovery over time.
This approach supports the evaluation of potential therapeutic drugs for nervous system repair and regeneration.

Reference:
https://www.hokudo.co.jp/4-1_kobetsushiken.html

Company Information

Address4-28, Hachiken 9-jo Nishi 10-chome, Nishi-ku, Sapporo, Hokkaido, Japan
Tel011-641-7507
Websitehttps://www.hokudo.co.jp
3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation
SMC Laboratories, Inc.
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)
  • SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
  • From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.

  • With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.
Safety Studies
Comprehensive Safety Evaluation for FIH Applications
Labcorp Holdings Inc.
(Labcorp Drug Development)
Labcorp Holdings Inc.
Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)
  • Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
  • The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
  • Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.
Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation
PhoenixBio Co., Ltd.
PhoenixBio Co., Ltd.
Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)
  • PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
  • With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.

  • The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

By region
list of animal models
Expertise & Track Record
3 Recommended Contract Non-Clinical Testing Services